Stenocare
1.29 DKK
-4.09 %
Less than 1K followers
STENO
First North Denmark
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Stenocare
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 14.79 | 10.36 | 5.45 | 4.85 | 1.42 | 0.73 | 1.48 |
| Shares | 18.0 | 22.1 | 22.1 | 22.1 | 32.9 | 36.2 | 43.2 |
| Market cap | 266.5 | 229.3 | 120.7 | 107.3 | 46.7 | 26.3 | 63.9 |
| Enterprise value | 260.9 | 203.0 | 110.3 | 113.8 | 46.9 | 28.6 | - |
| EV/S | 52.8 | 1,025.0 | 58.3 | 25.3 | 6.8 | 6.0 | - |
| EV/EBITDA | 59.1 | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | 59.9 | neg. | neg. | neg. | neg. | neg. | - |
| P/E | 156.6 | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 19.78 | 4.36 | 3.00 | 4.45 | 1.81 | -7.57 | 6.75 |
| P/S | 53.9 | 1,158.2 | 63.9 | 23.9 | 6.7 | 5.5 | 9.1 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 42.6 % | 93.2 % | 91.6 % | 61.0 % | 68.1 % | -17.6 % | 74.9 % |
| Gearing ratio | 119.6 % | - | 3.1 % | 45.1 % | 37.5 % | -107.5 % | 21.0 % |